What Pregnancy Reveals About a Woman's Long-Term Cardiometabolic Health

Pregnancy is often framed purely as an obstetric event, but Dr. Kathryn Gray — a physician-scientist and maternal-fetal medicine specialist at the University of Washington — makes a compelling case that it is also one of the most informative stress tests a woman's cardiometabolic system will ever undergo. In this episode of The Peter Attia Drive, she and Peter Attia explore how the cardiovascular, metabolic, and hormonal systems undergo dramatic adaptation during pregnancy — and what goes wrong when those adaptations fail.

The episode's longevity core lies in how gestational complications forecast long-term disease. Women who develop gestational diabetes face substantially elevated lifetime risk of type 2 diabetes and metabolic syndrome. Preeclampsia — a hypertensive disorder of pregnancy involving placental dysfunction — is now understood as a marker of underlying vascular and endothelial vulnerability, predicting future cardiovascular disease decades later. HELLP syndrome, a severe preeclampsia variant, carries additional long-term risk signals.

Gray explains the biology of preeclampsia in depth, including genetic findings that have illuminated placental mechanisms, and discusses which antihypertensive medications are used acutely and why. She also covers gestational diabetes screening and treatment, noting that a diagnosis mid-pregnancy represents a window for intervention that can alter both maternal and child health trajectories.

The episode also addresses exercise during pregnancy, prenatal nutrition and folate's role in neural tube development, breastfeeding evidence versus myth, cell-free DNA screening advances, and postpartum depression. Labor, delivery mode trade-offs, breech presentation, and stillbirth prevention are examined with clinical rigor.

For longevity-minded clinicians and health-conscious women, the key takeaway is actionable: pregnancy complications should trigger proactive long-term cardiometabolic monitoring and early intervention, not merely obstetric follow-up. Gray closes by highlighting critical research gaps in maternal health that, if addressed, could improve outcomes across the entire female lifespan.